series-a
Stage
2018
Founded
4
Investors
About
Aplagon is a clinical stage biopharmaceutical company developing first-in-class therapeutics for thromboinflammatory diseases, including thrombotic and vascular occlusion related cardiovascular diseases.
Explore Aplagon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.